Financial Data and Key Metrics Changes - In 2025, the company achieved approximately 2% volume-led organic growth, with 3% volume plus mix growth in Q4 despite a slowdown in global weighted average category growth to about 60 basis points [38][39] - Adjusted free cash flow for the year was $1.9 billion, consistent with previous estimates, indicating strong cash generation capabilities [39] - The company reported industry-leading gross productivity at 6.2% of Adjusted COGS, peaking at 7.2% in Q4, exceeding expectations [15] Business Line Data and Key Metrics Changes - The personal care business led productivity improvements, with significant progress in baby and childcare categories, reducing product platforms from 30 to 11 [16] - Innovations in personal care, such as Huggies' new products, contributed to share gains in key markets, with Huggies gaining nearly 50 basis points of share in Brazil in Q4 [23][28] - The company maintained healthy margins and strong exit momentum in Q4, with broad-based volume-led organic growth across all IPC focus markets [22] Market Data and Key Metrics Changes - In China, the company gained over 900 basis points of share in diapers over the past five years, while local competitors shifted focus to other markets [21] - The international personal care business saw broad-based share gains, with all focus markets delivering volume-led organic growth in Q4 [22] - The North American market demonstrated resilience, with positive volume mix-led growth for three consecutive years, despite competitive pressures [27][28] Company Strategy and Development Direction - The company is pivoting towards higher growth, higher margin personal care categories, including the sale of its Brazilian tissue operations and PPE business [4] - The acquisition of Kenvue is seen as a strategic move to enhance growth and create a consumer-centric health and wellness leader [5][6] - The company aims to achieve $2.1 billion in annual synergies from the Kenvue acquisition, with a focus on cost synergies and EPS accretion [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging environment, emphasizing a commitment to innovation and brand support [11][19] - The outlook for 2026 includes expectations for mid- to high-single-digit constant currency adjusted EPS growth, driven by the Kenvue acquisition and ongoing operational improvements [46][47] - The company anticipates continued pressure on consumers and a focus on value, but remains optimistic about its growth initiatives [11] Other Important Information - The company has made significant investments in its North American manufacturing footprint, including a $2 billion investment to enhance its supply chain [16] - The Powering Care strategy has created a virtuous cycle of growth, enabling the company to maintain resilience amid external challenges [10][12] - The company has improved its cash conversion cycle significantly, moving from 6 days in 2021 to around negative 10 days by the end of 2025 [43] Q&A Session Summary Question: What are the expectations for the Kenvue acquisition? - The company expects the Kenvue acquisition to enhance growth and create significant value for shareholders, with a focus on achieving synergies and integrating the brands effectively [7][45] Question: How is the company addressing competitive pressures? - Management highlighted a disciplined approach to innovation and marketing, which has allowed the company to maintain market share and drive growth despite competitive challenges [19][27] Question: What is the outlook for 2026? - The company projects mid- to high-single-digit constant currency adjusted EPS growth for 2026, supported by strong operational performance and the Kenvue acquisition [46][47]

Financial Data and Key Metrics Changes - In 2025, the company achieved approximately 2% organic growth, supported by 3% volume plus mix growth, despite a slowdown in global weighted average category growth to roughly 60 basis points in Q4 [38][39] - Adjusted Free Cash Flow for the year was $1.9 billion, consistent with previous estimates, indicating strong cash generation capabilities [39] - The company reported industry-leading gross productivity at 6.2% of Adjusted COGS for the year, peaking at 7.2% in Q4, exceeding expectations [15] Business Line Data and Key Metrics Changes - The Personal Care business led the way in productivity improvements, with significant progress in delivering high-performing products at lower costs [16] - Innovations in the Personal Care segment, such as Huggies' new products, contributed to strong volume-led organic growth, particularly in key markets like China and Brazil [22][24] - The company exited a large private label diaper contract in North America, which impacted the overall performance but was part of a strategic realignment [38] Market Data and Key Metrics Changes - In the international Personal Care business, the company gained over 900 basis points of share in diapers over the past five years, while local competitors have struggled [20] - The company saw broad-based share gains in international focus markets, with all focus markets delivering volume-led organic growth in Q4 [22] - In North America, the company achieved a volume plus mix growth of 1.8% in Q4, with Personal Care growing value share by 20 basis points for the year [28] Company Strategy and Development Direction - The company is focused on transforming into a pure-play Personal Care company, pivoting its portfolio towards higher growth and higher margin categories [4] - The acquisition of Kenvue is seen as a strategic move to enhance growth and create a consumer-centric health and wellness leader [5][7] - The company aims to leverage its operating momentum to create significant value for shareholders and improve care standards for consumers globally [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging environment, citing strong execution of the Powering Care strategy as a key driver of success [19] - The outlook for 2026 includes expectations for mid- to high-single-digit constant currency growth in Adjusted Operating Profit, supported by a robust pipeline of initiatives [46][47] - Management acknowledged ongoing consumer pressure and a focus on value, indicating that these factors will persist in the near term [11] Other Important Information - The company has made significant investments in its North American manufacturing footprint, including a $2 billion investment to enhance its capabilities [16] - The integration of Kenvue is being led by a dedicated team, with strong progress reported in the early stages [18] - The company has achieved a strong cash conversion cycle improvement, going from 6 days in 2021 to around negative 10 days at the close of 2025 [43] Q&A Session Summary Question: What are the expectations for the Kenvue acquisition? - Management expects the Kenvue acquisition to create significant value and enhance growth, with a target of generating $2.1 billion in annual synergies net of reinvestment [7][51] Question: How is the company addressing competitive pressures? - The company is focused on out-innovating and out-marketing competitors, maintaining a disciplined approach to brand investments and consumer engagement [19][27] Question: What is the outlook for Adjusted EPS growth? - The company anticipates double-digit growth in Adjusted EPS from continuing operations on a constant currency basis, driven by the Kenvue acquisition and ongoing operational improvements [47][48]

Financial Data and Key Metrics Changes - In 2025, the company achieved approximately 2% volume-led organic growth, with a strong performance in the fourth quarter, delivering 3% volume plus mix growth despite a slowdown in global weighted average category growth to roughly 60 basis points [38][39] - Adjusted free cash flow for the year was $1.9 billion, consistent with previous estimates, indicating the company's ability to maintain performance across quarters [39][45] - The company reported industry-leading gross productivity at 6.2% of Adjusted COGS, peaking at 7.2% in the fourth quarter, exceeding expectations [15] Business Line Data and Key Metrics Changes - The personal care business led the way in productivity improvements, with significant progress in categories like baby and childcare, which are highly competitive [16] - The company pivoted its portfolio towards higher growth, higher margin personal care categories, including the sale of its Brazilian tissue operations and PPE business, and exiting approximately $650 million of private label business [4][5] - Innovations in the personal care segment, such as Huggies' new products, contributed to strong volume growth and market share gains in various regions [24][28] Market Data and Key Metrics Changes - In international personal care markets, the company gained over 900 basis points of share in diapers over the past five years, while local competitors shifted focus away from China [20] - The company saw broad-based share gains in international personal care focus markets, with all focus markets delivering volume-led organic growth in Q4 [21][22] - In North America, the company achieved a third consecutive year of positive volume mix-led growth, with personal care growing value share by 20 basis points [27][28] Company Strategy and Development Direction - The company is focused on its "Powering Care" strategy, which emphasizes innovation, cost discipline, and a pivot towards higher margin categories [3][4] - The acquisition of Kenvue is seen as a significant step in the company's transformation, expected to enhance growth and create a scaled health and wellness leader [5][6] - The company aims to build a consumer-centric care model with a portfolio of ten iconic billion-dollar brands across critical life stages [5] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging environment, citing strong execution and a focus on innovation-led growth [19][39] - The outlook for 2026 includes expectations for mid- to high-single-digit constant currency adjusted EPS growth, driven by the Kenvue acquisition and ongoing operational improvements [47][48] - The company anticipates continued pressure on consumers and a focus on value, but remains committed to supporting its brands and driving growth initiatives [11][47] Other Important Information - The company has made significant investments in its North American manufacturing footprint, including a $2 billion investment to build an advanced manufacturing facility and an automated distribution center [16] - The company has improved its cash conversion cycle from 6 days in 2021 to around negative 10 days at the close of 2025, reflecting better working capital discipline [43] - The company has achieved a strong overhead leverage, expanding adjusted operating profit margins by 100 basis points over the past two years [42] Q&A Session Summary Question: What are the expectations for the Kenvue acquisition? - Management expects the Kenvue acquisition to be quickly accretive to earnings and value-enhancing for shareholders, with a focus on achieving significant synergies [37][53] Question: How is the company addressing competitive pressures? - The company is maintaining a disciplined approach to innovation and marketing, focusing on delivering superior consumer value propositions to navigate competitive pressures [19][27] Question: What is the outlook for 2026? - The company projects mid- to high-single-digit constant currency adjusted EPS growth for 2026, supported by the Kenvue acquisition and ongoing operational improvements [47][48]

Company Overview - Once Upon a Farm PBC is preparing for its debut as a public company, with CEO John Foraker expected to play a significant role in its performance, alongside actress Jennifer Garner, who serves as a co-founder and board member [1][2]. Leadership Experience - John Foraker, previously the CEO of Annie's Inc., brings valuable experience to the company, which could positively influence investor confidence. Annie's had a successful IPO in 2012 and was sold for more than double its initial share price [2][3]. Celebrity Influence - The involvement of a celebrity like Jennifer Garner can enhance marketing efforts, particularly in sectors appealing to retail investors. However, historical data shows that celebrity-backed IPOs often underperform in the long term [4][6]. Historical Performance of Celebrity IPOs - There is a notable history of celebrity-backed IPOs that have struggled post-debut, such as Planet Hollywood and Martha Stewart's media company, which faced significant declines after initial success [5][6]. - A study indicates that there is an 8 out of 11 chance of losing money in celebrity IPOs, with many deals performing worse than the market over a span of four to five years [7].

Core Viewpoint - The Procter & Gamble Company (PG) reported mixed second-quarter 2026 results, reflecting challenges in the U.S. consumer sector but demonstrating resilience in its premium product offerings [2][3]. Financial Performance - PG reported a sales growth of 1%, totaling $22.21 billion, slightly below the consensus estimate of $22.28 billion, attributed to weak U.S. consumer spending and the effects of a government shutdown [3]. - Adjusted earnings per share (EPS) were $1.88, exceeding analyst expectations of $1.86, driven by pricing actions and favorable product mix [4]. - Core gross margin declined for the fifth consecutive quarter due to tariff pressures and investments in value-oriented packaging [4]. Market Outlook - The company reiterated its full-year sales and profit guidance, indicating confidence in navigating a challenging macroeconomic environment [5]. - PG's shares increased by 2%, reflecting investor focus on earnings stability and improving international growth despite the slight revenue miss [5]. Company Overview - PG is a global leader in consumer goods, offering a diversified portfolio of branded household, personal care, and health products across various everyday-use segments [6].

Core Insights - Bath & Body Works, Inc. (NYSE:BBWI) is recognized as one of the 14 Best Mid-Cap Dividend Stocks to buy currently [1] - Jefferies has restarted coverage of Bath & Body Works with a Hold rating and increased its price target to $24 from $16, reflecting a cautious outlook on consumer demand influenced by a K-shaped recovery [2] Product Development - The company has a robust pipeline of new products that are expected to boost sales and attract new customers, with potential expansions into shaving, facial care, haircare, and men's grooming [3] Market Expansion - Bath & Body Works has significant untapped potential outside the U.S., with international markets contributing only about 5% of total sales in fiscal 2024, indicating a clear opportunity for global expansion [4]

Core Insights - Ontex Group NV has launched its multi-liquid liner in Germany, with plans for further distribution across Europe, following positive consumer feedback where over 90% of women indicated they would recommend the product and repurchase it [1][2]. Product Overview - The multi-liquid liner is designed to meet the diverse needs of women, providing protection for menstrual flow, light bladder leaks, and daily vaginal discharges in a single product [2]. - The liner is approved as a medical device, offering up to 8 hours of leak protection and odour control, and is available in three sizes: regular, large, and extra large [3]. Company Commitment - Ontex emphasizes its understanding of the evolving needs of women throughout different life stages, aiming to provide comfort and protection with its multi-liquid liner, which is marketed as "One liner for all your needs" [4]. - The company collaborates with retail partners to ensure that its innovative and affordable solutions are accessible to women at all stages of life [4]. Company Background - Ontex is a prominent international developer and producer of personal care products, including baby care, feminine care, and adult care, primarily operating in Europe and North America [6]. - The company employs around 5,100 people and has a presence in 11 countries, with its products distributed in approximately 100 countries [6].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Bath & Body Works, Inc. securities for the period between June 4, 2024, and November 19, 2025, due to alleged misleading statements and failure to disclose critical information regarding the company's financial performance [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Bath & Body Works made materially false and misleading statements about its business strategy and financial results during the Class Period [5]. - Allegations include that the company's strategy of pursuing "adjacencies, collaborations and promotions" did not effectively grow the customer base or deliver the expected net sales growth [5]. - The lawsuit asserts that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results, leading to a failure to meet previously issued financial guidance [5]. Group 2: Participation Information - Investors who purchased Bath & Body Works securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the Court by March 16, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Industry Overview - The consumer staples sector underperformed significantly in 2025 but is expected to see a more favorable environment in 2026 due to easing sector-specific pressures and potential fiscal stimulus boosting demand [1] - The sector has a 70-percentage-point performance gap relative to tech stocks over the past three years, indicating a contrarian opportunity for long-term investors [1] - The Consumer Staples exchange-traded fund (NYSEArca: XLP) gained 7.5% in just six trading days to start 2026, marking the strongest short-term run since 2022 [1] Investment Opportunities - The S&P 500 has produced double-digit returns over the past three years, but a shift towards safer consumer staples stocks is advisable due to potential market corrections [2] - Consumer staples stocks not only offer solid upside potential but also provide significant, dependable dividends, making them attractive for conservative growth and income investors [2] Notable Companies - Altria Group Inc. (NYSE: MO) offers a compelling entry point for value investors with a 7.30% dividend yield and focuses on smoke-free products [5] - Hormel Foods Corp. (NYSE: HRL) has a reliable 5.05% dividend yield and is restructuring its portfolio to improve performance after a 25% decline in 2025 [9] - Kimberly-Clark Corp. (NYSE: KMB) has raised its dividend for 53 consecutive years, currently yielding 5.04%, and is acquiring Kenvue Inc. in a $48.7 billion deal [13][15] - PepsiCo Inc. (NYSE: PEP) reported solid earnings and has a 3.81% dividend yield, with a potential upside of over 50% due to strategic changes proposed by activist investor Elliott Investment Management [19][20] - Procter & Gamble Co. (NYSE: PG) has raised dividends for 70 straight years, with a current yield of 2.82%, focusing on branded consumer packaged goods [22][25]

Core Viewpoint - A class action securities lawsuit has been filed against Bath & Body Works, Inc. alleging securities fraud that affected investors between June 4, 2024, and November 9, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that the company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow the customer base and did not deliver the expected growth in net sales [2]. - It is alleged that as the company's strategy faltered, it relied on brand collaborations to mask weak underlying financial results [2]. - The complaint suggests that the company was unlikely to meet its previously issued financial guidance due to these issues, rendering positive statements about its business materially misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 13, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].